RELMADA THERAPEUTICS, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RELMADA THERAPEUTICS, INC. stock issued during period, value, issued for services for the quarter ending 2014-09-30 was $875.00K.
- RELMADA THERAPEUTICS, INC. stock issued during period, value, issued for services for fiscal 2016 was $204.53K, a 82.67% decline from fiscal 2015.
- RELMADA THERAPEUTICS, INC. stock issued during period, value, issued for services for fiscal 2015 was $1.18M.
- RELMADA THERAPEUTICS, INC. stock issued during period, value, issued for services for fiscal 2013 was $16.92K, a 17.50% decline from fiscal 2012.
- RELMADA THERAPEUTICS, INC. stock issued during period, value, issued for services for fiscal 2012 was $20.51K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2016-06-30 | $204.53K 10-K · filed 2017-09-28 | |
| 2015-06-30 | $1.18M 10-K · filed 2016-09-09 | |
| 2014-09-30 | $875.00K 10-Q · filed 2014-11-07 | |
| 2013-12-31 | $16.92K 10-K · filed 2015-09-11 | |
| 2012-12-31 | $20.51K 10-KT · filed 2014-09-09 | |
| 2011-12-31 | $143.50K 8-K · filed 2014-05-27 | |
| 2010-12-31 | $29.30K 8-K · filed 2014-05-27 | |
| 2009-12-31 | $21.20K 8-K · filed 2014-05-27 | |
| 2007-12-31 | $711.00K 8-K · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |